HLA-Gm/κm interaction in sarcoidosis. Suggestions for a complex genetic structure

European Respiratory Journal

Volumn 16, Issue 1, 2000, Pages 74-80

  Martinetti, M ^a   Dugoujon, J M ^c   Tinelli, C ^a   Cipriani, A ^d   Cortelazzo, A ^a   Salvaneschi, L ^a   Casali, L ^a   Semenzato, G ^b   Cuccia, M ^a   Luisetti, M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c CHU PURPAN   (France)

^d IRCCS Policlinico San Matteo ^*

Author keywords

Correspondence analysis; Immunogenetics; Multifactorial diseases

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN;

ADULT; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE STRUCTURE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; HUMAN TISSUE; MALE; MARKER GENE; PHENOTYPE; PRIORITY JOURNAL; SARCOIDOSIS; GENETIC EPISTASIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY;

ADULT; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; MALE; PHENOTYPE; POLYMORPHISM, GENETIC; SARCOIDOSIS, PULMONARY;

EID: 0033624635     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.16a13.x     Document Type: Article

References (33)

1. Semenzato G, Agostini C. Immunologic events in the development of interstitial lung disease: the paradigm of sarcoidosis. In: Schwarz M, King TE, eds. Interstitial Lung Disease. Hamilton, Ontario, B.C. Dekker Inc., 1995; pp. 229-250.
2. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-1234.
3. Petranyi GG. Susceptibility to autoimmune diseases: a multigenic viewpoint. Immunol Today 1992; 13: A19-A20.
4. Mossman BT, Mason R, McDonald JA, Gail DB. NHLBI Workshop Summary. Advances in molecular genetics, transgenic models, and gene therapy for the study of pulmonary diseases. Am J Respir Crit Care Med 1995; 151: 2065-2069.
5. Kitaichi M. Prevalence of sarcoidosis around the world. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 16-18.
6. Rybicki BA, Maliarik MJ, Major M, Popovich J Jr, Iannuzzi MC. Genetics of sarcoidosis. Clin Chest Med 1997; 18: 707-717.
7. Finco O, Martinetti M, Dondi E, Luisetti M, Pasturenzi L, Cuccia M. Sarcoidosis and major histocompatibility complex genes with special emphasis on BfF subtypes. Complement Inflam 1991; 8: 80-85.
8. Pasturenzi L, Martinetti M, Cuccia M, Cipriani A, Semenzato S, Luisetti M, and the Pavia-Padova Sarcoidosis Study Group. HLA class I, II, and III polymorphism in Italian patients with sarcoidosis. Chest 1993; 104: 1170-1175.
9. Martinetti M, Tinelli C, Kolek V, et al. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995; 152: 557-564.
10. Croce CM, Shander M, Martinis J, et al. Chromosomal location of the genes for human immunoglobulin heavy chains. Proc Natl A cad Sci USA 1979; 76: 3416-3419.
11. MacBride OW, Hieter PA, Holli GF, Swan D, Otley NC, Leder P. Chromosomal location of human kappa and lambda immunoglobulin light chain constant region genes. J Exp Med 1982; 155: 1480-1490.
12. Grunewald J, Olerup O, Persson U, Ohrn MB, Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA 1994; 91: 4965-4969.
13. Dugoujon JM, Cambon-Thomsen A. Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity 1995; 22: 245-260.
14. Greenacre M. Correspondence analysis in medical research. Stat Methods Med Res 1992; 1: 97-117.
15. Piazza A, Lonjou C. HLA in Europe and in Mediterranean countries. In: Charron D, ed. Genetic Diversity of HLA. Functional and Medical Implications. Paris, EDK Publisher, 1997; pp. 374-384.
16. Field LL, Dugoujon JM. Immunoglobulin allotyping (Gm, Km) of GAW5 families. Genet Epidemiol 1989; 6: 31-34.
17. Dugoujon JM, De Lange G, Blancher A, Alie-Daran S, Marty Y. Characterization of an IgG2,G2m(23) anti-RhD antibody. Vox Sang 1989; 57: 133-136.
18. Martinetti M, Tafi A, Dugoujon JM, Mazzacane D, Blanc M, Cuccia Belvedere M. Possible interaction between HLA and Ig light chain markers in susceptibility to uveitis. Dis Markers 1988; 6: 257-262.
19. Martinetti M, Dugoujon JM, Caforio AL, et al. HLA and immunoglobulin polymorphisms in idiopathic dilated cardiomyopathy. Hum Immunol 1992; 35: 193-199.
20. Lebart L, Marineau A, Warwick K, eds. Multivariate Descriptive Statistical Analysis. New York, Wiley, 1984.
21. Greenacre MJ, Degos L. Correspondence analysis of HLA gene frequency data from 124 population samples. Am J Hum Genet 1977; 29: 60-75.
22. Greenacre MJ. Theory and Applications of Correspondence Analysis. London, Academic Press, 1984.
23. Greenacre M. SIMCA: a program to perform simple correspondence analysis. Am Statist 1986; 51: 230-231.
24. Degli Esposti MA, Leaver LA, Christiansen FT, Witt CS, Abraham LJ, Dawkins RL. Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol 1992; 34: 242-252.
25. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997; 156: 1601-1605.
26. Kunikane H, Abe S, Tsuneta Y, et al. Role of HLA-DR antigens in Japanese patients with sarcoidosis. Am Rev Respir Dis 1987; 135: 688-691.
27. Nakao Y, Matsumoto H, Miyazaki T, et al. IgG heavy chains allotypes (Gm) in autoimmune diseases. Clin Exp Immunol 1980; 42: 20-26.
28. Whittingham S, Mackay IR, Mathews JD. HLA-GM interactions: clinical implications. Clin Immunol Allergy 1984; 4: 623-640.
29. Morell A, Vassali G, De Lange G, Skavril F, Ambrosino D, Siber G. Ig allotype-linked regulation of class and subclass composition of natural antibodies to group A streptococcal carbohydrate. J Immunol 1989; 142: 2495-2500.
30. Pandey JP, French MAH. GM phenotypes influence the concentration of the four subclasses of immunoglobulin G in normal serum. Hum Immunol 1996; 51: 99-102.
31. Newill CA, Johns CJ, Cohen BH, Diamond EL, Bias WB. Sarcoidosis HLA and immunoglobulin markers in Baltimore blacks. In: Chrétien J, Marsac J, Saltiel JC, eds. Sarcoidosis and other Granulomatous Diseases. Paris, Pergamon Press, 1983; pp. 253-256.
32. Eklund A, Grunewald J. The riddle of sarcoidosis: have novel techniques brought any new insights as to the causative agent? J Intern Med 1996; 240: 59-62.
33. Hunninghake GW, Crystal RG. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes. J Clin Invest 1981; 67: 86-92.